| | ZURICH (Reuters) - Roche's immunotherapy combination that includes Tecentriq, Avastin and chemotherapy will get an accelerated review by U.S. regulators for use as an initial treatment of a common form of lung cancer, the Swiss drugmaker said on Monday. | |
| (Reuters) - Many restaurants, supermarkets, convenience stores and movie theaters across the United States are required starting on Monday to clearly display food calorie counts as part of a push to trim expanding American waistlines and control healthcare costs. | |
| (Reuters) - The U.S. Food and Drug Administration on Friday approved Novartis AG's combination therapy to treat an aggressive type of thyroid cancer. | |
| (Reuters) - Iowa Governor Kim Reynolds signed into law on Friday a bill outlawing abortion after a fetal heartbeat is detected, which often occurs at six weeks and before a woman even realizes she is pregnant, and Reynolds acknowledged the likelihood of a court challenge. | |
| WASHINGTON (Reuters) - The U.S. Drug Enforcement Administration said on Friday it had suspended a Louisiana pharmaceutical distributor from selling controlled substances for allegedly selling unusually large quantities of opioids to pharmacies without reporting the sales. | |
| NEW YORK (Reuters) - Three-dimensional printers are letting doctors in Minnesota make simulated body parts in a hospital and a Brooklyn startup create rocket engines designed to put satellites into orbit, executives said Thursday at an event hosted by General Electric Co. | |
| (Reuters Health) - Surgeons' skills may improve with age, and male and female surgeons perform equally well, a recent U.S. study finds. | |
| GENEVA (Reuters) - Adults and children should consume a maximum of 10 percent of their daily calories in the form of saturated fat such as meat and butter and one percent from trans fats to reduce the risk of heart disease, the World Health Organization said on Friday. | |
| (Reuters Health) - Face masks available to consumers in China for protection against air pollution vary widely in their real-world performance, suggests a recent study. | |
| (Reuters) - U.S. Food and Drug Administration chief Scott Gottlieb on Thursday questioned whether rebates that drugmakers provide to health insurers should remain protected by federal law, sparking new concerns on Wall Street over efforts to curb drug pricing. | |
|
| |